Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)

M.J. Crawford, H. Killaspy, T.R. Barnes, B. Barrett, S. Byford, K. Clayton, J. Dinsmore, S. Floyd, A. Hoadley, T. Johnson, E. Kalaitzaki, M. King, B. Leurent, A. Maratos, F.A. O’Neill, D. Osborn, S. Patterson, T. Soteriou, P. Tyrer, Diane Waller

Research output: Book/ReportCommissioned reportResearchpeer-review

Abstract

Objective: To examine the clinical effectiveness and cost-effectiveness of referral to group art therapy plus standard care, compared with referral to an activity group plus standard care and standard care alone, among people with schizophrenia. Design: A three-arm, parallel group, single-blind, pragmatic, randomised controlled trial. Participants were randomised via an independent and remote telephone randomisation service using permuted blocks, stratified by study centre. Setting: Study participants were recruited from secondary care mental health and social services in four UK centres. Participants: Potential participants were aged 18 years or over, had a clinical diagnosis of schizophrenia, confirmed by an examination of case notes, and provided written informed consent. We excluded those who were unable to speak sufficient English to complete the baseline assessment, those with severe cognitive impairment and those already receiving arts therapy. Interventions: Group art therapy was delivered by registered art therapists according to nationally agreed standards. Groups had up to eight members, lasted for 90 minutes and ran for 12 months. Members were given access to a range of art materials and encouraged to use these to express themselves freely. Activity groups were designed to control for the non-specific effects of group art therapy. Group facilitators offered various activities and encouraged participants to collectively select those they wanted to pursue. Standard care involved follow-up from secondary care mental health services and the option of referral to other services, except arts therapies, as required. Main outcome measures: Our co-primary outcomes were global functioning (measured using the Global Assessment of Functioning Scale – GAF) and mental health symptoms (measured using the Positive and Negative Syndrome Scale – PANSS) at 24 months. The main secondary outcomes were level of group attendance, social functioning, well-being,
Original languageEnglish
Place of PublicationBasingstoke, UK
PublisherNIHR Health Technology Assessment Programme
Number of pages76
Volume16
DOIs
Publication statusPublished - 1 Feb 2012

Fingerprint

Art Therapy
Group Psychotherapy
Schizophrenia
Randomized Controlled Trials
Secondary Care
Referral and Consultation
Mental Health Services
Art
Therapeutics
Aftercare
Standard of Care
Random Allocation
Informed Consent
Social Work
Telephone
Cost-Benefit Analysis
Mental Health
Outcome Assessment (Health Care)

Bibliographical note

© Queen's Printer and Controller of HMSO 2012. This work was produced by Crawford et al under the terms of a commissioning contract issued by the Secretary of State for Health. Dianne Waller on behalf of the MATISSE project team.

Cite this

Crawford, M. J., Killaspy, H., Barnes, T. R., Barrett, B., Byford, S., Clayton, K., ... Waller, D. (2012). Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE). Basingstoke, UK: NIHR Health Technology Assessment Programme. https://doi.org/10.3310/hta16080
Crawford, M.J. ; Killaspy, H. ; Barnes, T.R. ; Barrett, B. ; Byford, S. ; Clayton, K. ; Dinsmore, J. ; Floyd, S. ; Hoadley, A. ; Johnson, T. ; Kalaitzaki, E. ; King, M. ; Leurent, B. ; Maratos, A. ; O’Neill, F.A. ; Osborn, D. ; Patterson, S. ; Soteriou, T. ; Tyrer, P. ; Waller, Diane. / Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE). Basingstoke, UK : NIHR Health Technology Assessment Programme, 2012. 76 p.
@book{14448646a89d4014ab11d515535beff7,
title = "Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)",
abstract = "Objective: To examine the clinical effectiveness and cost-effectiveness of referral to group art therapy plus standard care, compared with referral to an activity group plus standard care and standard care alone, among people with schizophrenia. Design: A three-arm, parallel group, single-blind, pragmatic, randomised controlled trial. Participants were randomised via an independent and remote telephone randomisation service using permuted blocks, stratified by study centre. Setting: Study participants were recruited from secondary care mental health and social services in four UK centres. Participants: Potential participants were aged 18 years or over, had a clinical diagnosis of schizophrenia, confirmed by an examination of case notes, and provided written informed consent. We excluded those who were unable to speak sufficient English to complete the baseline assessment, those with severe cognitive impairment and those already receiving arts therapy. Interventions: Group art therapy was delivered by registered art therapists according to nationally agreed standards. Groups had up to eight members, lasted for 90 minutes and ran for 12 months. Members were given access to a range of art materials and encouraged to use these to express themselves freely. Activity groups were designed to control for the non-specific effects of group art therapy. Group facilitators offered various activities and encouraged participants to collectively select those they wanted to pursue. Standard care involved follow-up from secondary care mental health services and the option of referral to other services, except arts therapies, as required. Main outcome measures: Our co-primary outcomes were global functioning (measured using the Global Assessment of Functioning Scale – GAF) and mental health symptoms (measured using the Positive and Negative Syndrome Scale – PANSS) at 24 months. The main secondary outcomes were level of group attendance, social functioning, well-being,",
author = "M.J. Crawford and H. Killaspy and T.R. Barnes and B. Barrett and S. Byford and K. Clayton and J. Dinsmore and S. Floyd and A. Hoadley and T. Johnson and E. Kalaitzaki and M. King and B. Leurent and A. Maratos and F.A. O’Neill and D. Osborn and S. Patterson and T. Soteriou and P. Tyrer and Diane Waller",
note = "{\circledC} Queen's Printer and Controller of HMSO 2012. This work was produced by Crawford et al under the terms of a commissioning contract issued by the Secretary of State for Health. Dianne Waller on behalf of the MATISSE project team.",
year = "2012",
month = "2",
day = "1",
doi = "10.3310/hta16080",
language = "English",
volume = "16",
publisher = "NIHR Health Technology Assessment Programme",

}

Crawford, MJ, Killaspy, H, Barnes, TR, Barrett, B, Byford, S, Clayton, K, Dinsmore, J, Floyd, S, Hoadley, A, Johnson, T, Kalaitzaki, E, King, M, Leurent, B, Maratos, A, O’Neill, FA, Osborn, D, Patterson, S, Soteriou, T, Tyrer, P & Waller, D 2012, Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE). vol. 16, NIHR Health Technology Assessment Programme, Basingstoke, UK. https://doi.org/10.3310/hta16080

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE). / Crawford, M.J.; Killaspy, H.; Barnes, T.R.; Barrett, B.; Byford, S.; Clayton, K.; Dinsmore, J.; Floyd, S.; Hoadley, A.; Johnson, T.; Kalaitzaki, E.; King, M.; Leurent, B.; Maratos, A.; O’Neill, F.A.; Osborn, D.; Patterson, S.; Soteriou, T.; Tyrer, P.; Waller, Diane.

Basingstoke, UK : NIHR Health Technology Assessment Programme, 2012. 76 p.

Research output: Book/ReportCommissioned reportResearchpeer-review

TY - BOOK

T1 - Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)

AU - Crawford, M.J.

AU - Killaspy, H.

AU - Barnes, T.R.

AU - Barrett, B.

AU - Byford, S.

AU - Clayton, K.

AU - Dinsmore, J.

AU - Floyd, S.

AU - Hoadley, A.

AU - Johnson, T.

AU - Kalaitzaki, E.

AU - King, M.

AU - Leurent, B.

AU - Maratos, A.

AU - O’Neill, F.A.

AU - Osborn, D.

AU - Patterson, S.

AU - Soteriou, T.

AU - Tyrer, P.

AU - Waller, Diane

N1 - © Queen's Printer and Controller of HMSO 2012. This work was produced by Crawford et al under the terms of a commissioning contract issued by the Secretary of State for Health. Dianne Waller on behalf of the MATISSE project team.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Objective: To examine the clinical effectiveness and cost-effectiveness of referral to group art therapy plus standard care, compared with referral to an activity group plus standard care and standard care alone, among people with schizophrenia. Design: A three-arm, parallel group, single-blind, pragmatic, randomised controlled trial. Participants were randomised via an independent and remote telephone randomisation service using permuted blocks, stratified by study centre. Setting: Study participants were recruited from secondary care mental health and social services in four UK centres. Participants: Potential participants were aged 18 years or over, had a clinical diagnosis of schizophrenia, confirmed by an examination of case notes, and provided written informed consent. We excluded those who were unable to speak sufficient English to complete the baseline assessment, those with severe cognitive impairment and those already receiving arts therapy. Interventions: Group art therapy was delivered by registered art therapists according to nationally agreed standards. Groups had up to eight members, lasted for 90 minutes and ran for 12 months. Members were given access to a range of art materials and encouraged to use these to express themselves freely. Activity groups were designed to control for the non-specific effects of group art therapy. Group facilitators offered various activities and encouraged participants to collectively select those they wanted to pursue. Standard care involved follow-up from secondary care mental health services and the option of referral to other services, except arts therapies, as required. Main outcome measures: Our co-primary outcomes were global functioning (measured using the Global Assessment of Functioning Scale – GAF) and mental health symptoms (measured using the Positive and Negative Syndrome Scale – PANSS) at 24 months. The main secondary outcomes were level of group attendance, social functioning, well-being,

AB - Objective: To examine the clinical effectiveness and cost-effectiveness of referral to group art therapy plus standard care, compared with referral to an activity group plus standard care and standard care alone, among people with schizophrenia. Design: A three-arm, parallel group, single-blind, pragmatic, randomised controlled trial. Participants were randomised via an independent and remote telephone randomisation service using permuted blocks, stratified by study centre. Setting: Study participants were recruited from secondary care mental health and social services in four UK centres. Participants: Potential participants were aged 18 years or over, had a clinical diagnosis of schizophrenia, confirmed by an examination of case notes, and provided written informed consent. We excluded those who were unable to speak sufficient English to complete the baseline assessment, those with severe cognitive impairment and those already receiving arts therapy. Interventions: Group art therapy was delivered by registered art therapists according to nationally agreed standards. Groups had up to eight members, lasted for 90 minutes and ran for 12 months. Members were given access to a range of art materials and encouraged to use these to express themselves freely. Activity groups were designed to control for the non-specific effects of group art therapy. Group facilitators offered various activities and encouraged participants to collectively select those they wanted to pursue. Standard care involved follow-up from secondary care mental health services and the option of referral to other services, except arts therapies, as required. Main outcome measures: Our co-primary outcomes were global functioning (measured using the Global Assessment of Functioning Scale – GAF) and mental health symptoms (measured using the Positive and Negative Syndrome Scale – PANSS) at 24 months. The main secondary outcomes were level of group attendance, social functioning, well-being,

U2 - 10.3310/hta16080

DO - 10.3310/hta16080

M3 - Commissioned report

VL - 16

BT - Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)

PB - NIHR Health Technology Assessment Programme

CY - Basingstoke, UK

ER -

Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K et al. Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE). Basingstoke, UK: NIHR Health Technology Assessment Programme, 2012. 76 p. https://doi.org/10.3310/hta16080